APA

Sieben N. L. G., Macropoulos P., Roemen G. M. J. M., Kolkman-Uljee S. M., Jan Fleuren G., Houmadi R., Diss T., Warren B., Al Adnani M., De Goeij A. P. M., Krausz T. & Flanagan A. M. (20040416). In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. : The Journal of pathology.

Chicago

Sieben Nathalie L G, Macropoulos Patricia, Roemen Guido M J M, Kolkman-Uljee Sandra M, Jan Fleuren Gert, Houmadi Rifat, Diss Tim, Warren Bretta, Al Adnani Mudher, De Goeij Anton P M, Krausz Thomas and Flanagan Adrienne M. 20040416. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. : The Journal of pathology.

Harvard

Sieben N. L. G., Macropoulos P., Roemen G. M. J. M., Kolkman-Uljee S. M., Jan Fleuren G., Houmadi R., Diss T., Warren B., Al Adnani M., De Goeij A. P. M., Krausz T. and Flanagan A. M. (20040416). In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. : The Journal of pathology.

MLA

Sieben Nathalie L G, Macropoulos Patricia, Roemen Guido M J M, Kolkman-Uljee Sandra M, Jan Fleuren Gert, Houmadi Rifat, Diss Tim, Warren Bretta, Al Adnani Mudher, De Goeij Anton P M, Krausz Thomas and Flanagan Adrienne M. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours. : The Journal of pathology. 20040416.